Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Sleep Medicine

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.sleep.2013.06.008PMID 23948220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series.

  2013cited by this paper
• Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson’s disease and normal control

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (RBD): 16 year update on a previously reported series

  2013cited by this paper
• Interobserver variability, and visual and quantitative parameters of 123I-FP-CIT SPECT (DaTSCAN) studies

  2012cited by this paper
• [Olfactory dysfunction in Parkinson disease and REM sleep behavior disorder].

  2012cited by this paper
• How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.

  2012cited by this paper
• Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.

  2011cited by this paper
• Mild parkinsonian signs in a community-dwelling elderly population sample in Japan.

  2011cited by this paper
• SPECT imaging evaluation in movement disorders: far beyond visual assessment

  2011cited by this paper
• Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder

  2011cited by this paper
• REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

  2010cited by this paper
• Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population‐based study of elders

  2010cited by this paper
• Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder.

  2010cited by this paper
• Olfactory dysfunction in idiopathic REM sleep behavior disorder.

  2010cited by this paper
• Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

  2010cited by this paper
• Shape analysis of 123I-N-ω-fluoropropyl-2-&bgr;-carbomethoxy-3&bgr;-(4-iodophenyl) nortropane single-photon emission computed tomography images in the assessment of patients with parkinsonian syndromes

  2009cited by this paper
• The impact of reconstruction method on the quantification of DaTSCAN images

  2009cited by this paper
• Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder

  2009cited by this paper
• Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.

  2009cited by this paper
• TRANSCRANIAL SONOGRAPHY IN MOVEMENT DISORDERS

  2009cited by this paper
• A comparative study of odor identification and odor discrimination deficits in Parkinson's disease

  2008cited by this paper
• Transcranial sonography in movement disorders.

  2008cited by this paper
• Assessment of idiopathic rapid‐eye‐movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP‐CIT‐SPECT

  2008cited by this paper
• Association of olfactory dysfunction with risk for future Parkinson's disease

  2008cited by this paper
• The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.

  2008cited by this paper
• Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity.

  2008cited by this paper
• Mild Parkinsonian signs: An overview of an emerging concept

  2007cited by this paper
• Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease

  2007cited by this paper
• Relation between subtype of Parkinson's disease and REM sleep behavior disorder.

  2007cited by this paper
• Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.

  2007cited by this paper
• The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications

  2007cited by this paper
• Functional correlates of mild parkinsonian signs in the community‐dwelling elderly: Poor balance and inability to ambulate independently

  2006cited by this paper
• Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder

  2006cited by this paper
• Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study.

  2006cited by this paper
• Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder.

  2006cited by this paper
• Comparative analysis of visual and semi-quantitative assessment of striatal [123I]FP-CIT-SPET binding in Parkinson's disease

  2006cited by this paper
• Global prevalence of dementia: a Delphi consensus study

  2005cited by this paper
• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms

  2005cited by this paper
• Five‐year follow‐up study of hyperechogenicity of the substantia nigra in Parkinson's disease

  2005cited by this paper
• Impact of dopamine transporter SPECT using 123I‐Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes

  2004cited by this paper
• Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

  2004cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003influential reference
• Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes

  2002cited by this paper
• Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis

  2001cited by this paper
• Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds

  2000cited by this paper
• Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

  1999cited by this paper
• Terry: Violent Behavior During Sleep

  1997cited by this paper
• Violent behavior during sleep.

  1997cited by this paper
• [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

  1997cited by this paper
• Dosimetry of an iodine-123-labeled tropane to image dopamine transporters.

  1996cited by this paper
• Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder

  1996cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• Olfactory dysfunction in parkinsonism

  1988cited by this paper
• Smell identification ability: changes with age.

  1984cited by this paper

• Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson’s disease

  2025cites this paper
• Dopaminergic damage pattern predicts phenoconversion time in isolated rapid eye movement sleep behavior disorder

  2023cites this paper
• Brain glucose metabolism and nigrostriatal degeneration in isolated rapid eye movement sleep behaviour disorder

  2023cites this paper
• Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage

  2023cites this paper
• Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson's disease

  2022cites this paper
• Neurochemical Features of Rem Sleep Behaviour Disorder

  2021influential citation
• Bidirectional Association Between Sleep and Brain Atrophy in Aging

  2021cites this paper
• VMAT2 availability in Parkinson’s disease with probable REM sleep behaviour disorder

  2021cites this paper
• VMAT2 Availability in Parkinson’s Disease with REM Sleep Behaviour Disorder

  2021cites this paper
• Assessing brain iron and volume of subcortical nuclei in idiopathic rapid eye movement sleep behavior disorder.

  2021cites this paper
• Progress in the Study of Imaging Biomarkers of Parkinson’s Disease with REM Sleep Behaviour Disorder

  2020influential citation
• Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder

  2020cites this paper
• Brain Imaging in RBD

  2019cites this paper
• Neuroimaging of Rapid Eye Movement Sleep Behavior Disorder.

  2019cites this paper
• Biomarkers of Neurodegenerative Disease in Idiopathic RBD

  2019cites this paper
• Neuropsychological, electrophysiological, and neuroimaging biomarkers for REM behavior disorder

  2019cites this paper
• Transcranial B-Mode Sonography in Movement Disorders.

  2018cites this paper
• Idiopathic REM sleep behaviour disorder and neurodegeneration — an update

  2018cites this paper
• Research Progress of Radionuclide Imaging in Rapid-Eye Movement Sleep Behavior Disorder (RBD)

  2018cites this paper
• Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson’s Disease and Other Synucleinopathies

  2018cites this paper
• Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate?

  2017cites this paper
• Neuroimaging in pre-motor Parkinson's disease

  2017cites this paper
• Chapter 103 – Rapid Eye Movement Sleep Parasomnias

  2017cites this paper
• Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk?

  2017cites this paper
• Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism

  2017cites this paper
• Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder

  2017cites this paper
• Brain imaging findings in idiopathic REM sleep behavior disorder (RBD) - A systematic review on potential biomarkers for neurodegeneration.

  2017cites this paper
• Transcranial sonography in idiopathic REM sleep behavior disorder and multiple system atrophy

  2017cites this paper
• The Prevalence and Characteristics of REM Sleep without Atonia (RSWA) in Patients Taking Antidepressants

  2016cites this paper
• Study on transcranial sonography in patients with idiopathic rapid eye movement sleep behavior disorder

  2016cites this paper
• Clinical markers of neurodegeneration in Chinese patients with idiopathic rapid eye movement sleep behavior disorder.

  2016cites this paper
• Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?

  2015cites this paper
• Clinical Biomarkers of Neurodegeneration in REM Sleep Behavior Disorder

  2015cites this paper
• Functional imaging in pre-motor Parkinson's disease.

  2014cites this paper
• REM Sleep Behavior Disorder (RBD) as a marker of neurodegenerative disorders.

  2014cites this paper
• Porucha chování v REM spánku - nozologická jednotka s velkým významem pro neurologii

  2014cites this paper